163 related articles for article (PubMed ID: 20820096)
21. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis.
Fischer T; Gemeinhardt I; Wagner S; Stieglitz DV; Schnorr J; Hermann KG; Ebert B; Petzelt D; Macdonald R; Licha K; Schirner M; Krenn V; Kamradt T; Taupitz M
Acad Radiol; 2006 Jan; 13(1):4-13. PubMed ID: 16399028
[TBL] [Abstract][Full Text] [Related]
22. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
23. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
24. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
He W; Horn SW; Hussain MD
Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, fluorescence and biodistribution of a bone-targeted near-infrared conjugate.
Mizrahi DM; Ziv-Polat O; Perlstein B; Gluz E; Margel S
Eur J Med Chem; 2011 Oct; 46(10):5175-83. PubMed ID: 21903304
[TBL] [Abstract][Full Text] [Related]
26. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
27. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
28. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein.
Cai C; Bakowsky U; Rytting E; Schaper AK; Kissel T
Eur J Pharm Biopharm; 2008 May; 69(1):31-42. PubMed ID: 18023160
[TBL] [Abstract][Full Text] [Related]
29. Targeting intracellular compartments by magnetic polymeric nanoparticles.
Kocbek P; Kralj S; Kreft ME; Kristl J
Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
[TBL] [Abstract][Full Text] [Related]
30. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
31. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
Kim BS; Kim CS; Lee KM
Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
33. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
34. Near infrared dye indocyanine green doped silica nanoparticles for biological imaging.
Quan B; Choi K; Kim YH; Kang KW; Chung DS
Talanta; 2012 Sep; 99():387-93. PubMed ID: 22967569
[TBL] [Abstract][Full Text] [Related]
35. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
[TBL] [Abstract][Full Text] [Related]
36. Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles.
Mérian J; Boisgard R; Bayle PA; Bardet M; Tavitian B; Texier I
Eur J Pharm Biopharm; 2015 Jun; 93():1-10. PubMed ID: 25805562
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
38. Near-infrared dye-loaded PLGA nanoparticles prepared by spray drying for photoacoustic applications.
Kohl Y; Kaiser C; Bost W; Stracke F; Thielecke H; Wischke C; Lendlein A; Kratz K; Lemor R
Int J Artif Organs; 2011 Feb; 34(2):249-52. PubMed ID: 21374564
[TBL] [Abstract][Full Text] [Related]
39. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery.
Yi F; Wu H; Jia GL
J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119
[TBL] [Abstract][Full Text] [Related]
40. Formation of near-infrared fluorescent nanoparticles for medical imaging.
Larush L; Magdassi S
Nanomedicine (Lond); 2011 Feb; 6(2):233-40. PubMed ID: 21385126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
